Cat. No.: HY-W012349

2′-Hydroxychalcone

Customer Review

Based on 1 Customer Validation

2′-Hydroxychalcone is a hydroxyl derivative of chalcones with anticancer activities. 2'-Hydroxychalcone inhibits NF-κB pathway and induces autophagy and apoptosis in breast cancer cells. 2′-Hydroxychalcone shows a better antifungal activity against the complex Paracoccidioides spp.

For research use only. We do not sell to patients.

Purity: 97.45%
CAS No.: 1214-47-7
Formula: C₁₅H₁₂O₂
Molecular Weight:224.25

Storage:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

2′-Hydroxychalcone Chemical Structure

CAS No.: 1214-47-7

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Solvent & Solubility
- In Vitro
Purity & Documentation
References
Help & FAQs
Classifications
Bioz

Biological Activity

Description

2′-Hydroxychalcone is a hydroxyl derivative of chalcones with anticancer activities. 2'-Hydroxychalcone inhibits NF-κB pathway and induces autophagy and apoptosis in breast cancer cells^[1]. 2′-Hydroxychalcone shows a better antifungal activity against the complex Paracoccidioides spp^[2].

All NF-κB Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
A2780cisR	GI₅₀	13.45 μM Compound: 6	Growth inhibition of cisplatin-resistant human A2780cis cells after 7 days by crystal violet staining based clonogenic assay Growth inhibition of cisplatin-resistant human A2780cis cells after 7 days by crystal violet staining based clonogenic assay	[PMID: 24565968]
A549	IC₅₀	>20 μM Compound: 2	Inhibition of TNFalpha induced NF-kappaB activation in human A549 cells by luciferase reporter gene assay Inhibition of TNFalpha induced NF-kappaB activation in human A549 cells by luciferase reporter gene assay	[PMID: 19883086]
HK-2	IC₅₀	24.4 μM Compound: 8	Growth inhibition of HK2 cells by sulforhodamine assay Growth inhibition of HK2 cells by sulforhodamine assay	[PMID: 17383189]
HL-60	IC₅₀	18 μM Compound: 2	Cytotoxicity against human HL60 cells by MTT assay Cytotoxicity against human HL60 cells by MTT assay	[PMID: 25091929]
HSC-2	CC₅₀	58 μM Compound: 2'-hydroxychalcone	Cytotoxicity against human HSC2 cells Cytotoxicity against human HSC2 cells	[PMID: 11429996]
HT-29	IC₅₀	85 μM Compound: 8	Growth inhibition of HT29 cells by sulforhodamine assay Growth inhibition of HT29 cells by sulforhodamine assay	[PMID: 17383189]
K562	IC₅₀	60.7 μM Compound: 1	Cytotoxicity against Homo sapiens (human) K562 cells after 72 hr by MTT assay Cytotoxicity against Homo sapiens (human) K562 cells after 72 hr by MTT assay	10.1007/s00044-010-9344-z
L929	CC₅₀	79.5 μM Compound: 1	Cytotoxicity in mouse NCTC-929 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay Cytotoxicity in mouse NCTC-929 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay	[PMID: 31000155]
MCF7	IC₅₀	28.4 μM Compound: 2a	The compound was tested for antiproliferative activity against MCF-7 human breast cancer cells The compound was tested for antiproliferative activity against MCF-7 human breast cancer cells	[PMID: 11720850]
MCF7	IC₅₀	78 μM Compound: 8	Growth inhibition of MCF7 cells by sulforhodamine assay Growth inhibition of MCF7 cells by sulforhodamine assay	[PMID: 17383189]
MOLM-13	GI₅₀	>10 μM Compound: 1	Antiproliferative activity against human MOLM-13 cells assessed as reduction in cell viability after 72 hrs by MTS assay Antiproliferative activity against human MOLM-13 cells assessed as reduction in cell viability after 72 hrs by MTS assay	[PMID: 32975953]
MV4-11	GI₅₀	>10 μM Compound: 1	Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability after 72 hrs by MTS assay Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability after 72 hrs by MTS assay	[PMID: 32975953]
NALM-6	IC₅₀	37.5 μM Compound: 2	Cytotoxicity against human NALM6 cells by MTT assay Cytotoxicity against human NALM6 cells by MTT assay	[PMID: 25091929]
PBMC	IC₅₀	11 μg/mL Compound: 15	Immunosuppressive activity in human PBMC assessed as inhibition of PHA-induced T cell proliferation after 72 hrs by [3H]thymidine incorporation assay Immunosuppressive activity in human PBMC assessed as inhibition of PHA-induced T cell proliferation after 72 hrs by [3H]thymidine incorporation assay	10.1007/s00044-013-0564-x
PBMC	IC₅₀	19.7 μg/mL Compound: 15	Immunosuppressive activity in human PBMC assessed as inhibition of PHA/PMA-induced IL-2 production after 18 hrs by ELISA Immunosuppressive activity in human PBMC assessed as inhibition of PHA/PMA-induced IL-2 production after 18 hrs by ELISA	10.1007/s00044-013-0564-x
SK-N-MC	IC₅₀	61.2 μM Compound: 1	Cytotoxicity against Homo sapiens (human) SK-N-MC cells after 72 hr by MTT assay Cytotoxicity against Homo sapiens (human) SK-N-MC cells after 72 hr by MTT assay	10.1007/s00044-010-9344-z
THP-1	GI₅₀	>10 μM Compound: 1	Antiproliferative activity against human THP-1 cells assessed as reduction in cell viability after 72 hrs by MTS assay Antiproliferative activity against human THP-1 cells assessed as reduction in cell viability after 72 hrs by MTS assay	[PMID: 32975953]
TK-10	IC₅₀	79 μM Compound: 8	Growth inhibition of TK10 cells by sulforhodamine assay Growth inhibition of TK10 cells by sulforhodamine assay	[PMID: 17383189]
WM-115	IC₅₀	40.8 μM Compound: 2	Cytotoxicity against human WM115 cells by MTT assay Cytotoxicity against human WM115 cells by MTT assay	[PMID: 25091929]

In Vitro

2′-Hydroxychalcone (10-90 μM; 12-72 h) suppresses cell viability in a dose-dependent manner, with IC₅₀ values of 37.74 μM and 34.26 μM for the two breast cancer cell lines MCF-7 and CMT-1211, respectively^[1].
2′-Hydroxychalcone (10-30 μM; 24 h) promotes autophagy vesicle accumulation in breast cancer cells^[1].
2′-Hydroxychalcone (30 μM; 24 h) induces autophagy-dependent apoptosis in breast cancer cells, and increases cleavage of caspase-3 and PARP^[1].
2′-Hydroxychalcone (10-30 μM; 24 h) significantly reduces the expression of p-IκB and p-NF-κBp65, and elevates the levels of p-ERK and p-JNK^[1].
2′-Hydroxychalcone (30 μM; 12-24 h) increased the intracellular ROS levels and triggered endoplasmic reticulum stress (ERS) of breast cancer cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:

MCF-7 and CMT-1211 cells
Concentration:

10 μM, 20 μM, 30 μM, 40 μM, 50 μM, 60 μM, 70 μM, 80 μM, and 90 μM
Incubation Time:

12 h, 24 h, 36 h, 48 h, 60 h, and 72 h
Result:

Suppressed cell viability in a dose-dependent manner.

Cell Autophagy Assay^[1]

Cell Line:

MCF-7 and CMT-1211 cells
Concentration:

10 μM, 20 μM, 30 μM
Incubation Time:

24 h
Result:

Induced autophagy and promoted autophagy flux in breast cancer cells.

Apoptosis Analysis^[1]

Cell Line:

MCF-7 and CMT-1211 cells
Concentration:

30 μM
Incubation Time:

24 h
Result:

Induced autophagy-dependent apoptosis of breast cancer cells.

Western Blot Analysis^[1]

Cell Line:

MCF-7 and CMT-1211 cells
Concentration:

10 μM, 20 μM, 30 μM
Incubation Time:

24 h
Result:

Regulated MAPK/NF-κB signaling pathways and inhibited migration/invasion of breast cancer cells.

In Vivo

2'-Hydroxychalcone (20-60 mg/kg; ip; every 2 days; 3 weeks) could exhibit an antitumor effect in vivo without causing significant toxicity to essential organs^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Five-week-old Balb/C female mice injected with CMT-1211 cells^[1]
Dosage:

20 mg/kg, 40 mg/kg, 60 mg/kg
Administration:

Intraperitoneal injection; every 2 days; 3 weeks
Result:

Suppressed tumor growth and metastasis in vivo.

Chemical Information

CAS No. 1214-47-7
Appearance Solid
Molecular Weight 224.25
Formula C₁₅H₁₂O₂
Color Light yellow to yellow
SMILES

O=C(C1=C(O)C=CC=C1)/C=C/C2=CC=CC=C2
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : 200 mg/mL (891.86 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

4.4593 mL

22.2965 mL

44.5931 mL

5 mM

0.8919 mL

4.4593 mL

8.9186 mL

10 mM

0.4459 mL

2.2297 mL

4.4593 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (278 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Xiao Wang, et al. 2'-Hydroxychalcone Induces Autophagy and Apoptosis in Breast Cancer Cells via the Inhibition of the NF-κB Signaling Pathway: In Vitro and In Vivo Studies. Nutrients. 2024 Feb 13;16(4):514. [Content Brief]

[2]. Kaila P Medina-Alarcón, et al. Antifungal activity of 2'-hydroxychalcone loaded in nanoemulsion against Paracoccidioides spp. Future Microbiol. 2020 Jan:15:21-33. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	4.4593 mL	22.2965 mL	44.5931 mL	111.4827 mL
	5 mM	0.8919 mL	4.4593 mL	8.9186 mL	22.2965 mL
	10 mM	0.4459 mL	2.2297 mL	4.4593 mL	11.1483 mL
	15 mM	0.2973 mL	1.4864 mL	2.9729 mL	7.4322 mL
	20 mM	0.2230 mL	1.1148 mL	2.2297 mL	5.5741 mL
	25 mM	0.1784 mL	0.8919 mL	1.7837 mL	4.4593 mL
	30 mM	0.1486 mL	0.7432 mL	1.4864 mL	3.7161 mL
	40 mM	0.1115 mL	0.5574 mL	1.1148 mL	2.7871 mL
	50 mM	0.0892 mL	0.4459 mL	0.8919 mL	2.2297 mL
	60 mM	0.0743 mL	0.3716 mL	0.7432 mL	1.8580 mL
	80 mM	0.0557 mL	0.2787 mL	0.5574 mL	1.3935 mL
	100 mM	0.0446 mL	0.2230 mL	0.4459 mL	1.1148 mL

Keywords

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

2′-Hydroxychalcone

All NF-κB Isoforms

Biological Activity

Chemical Information

Solvent & Solubility

Purity & Documentation

References

Help & FAQs

Complete Stock Solution Preparation Table

2′-Hydroxychalcone Related Classifications

HY-W012349 Related Classifications